Cargando…
Targeting RIPK1 kinase for modulating inflammation in human diseases
Receptor-Interacting Serine/Threonine-Protein Kinase 1 (RIPK1) is a master regulator of TNFR1 signaling in controlling cell death and survival. While the scaffold of RIPK1 participates in the canonical NF-κB pathway, the activation of RIPK1 kinase promotes not only necroptosis and apoptosis, but als...
Autores principales: | Li, Wanjin, Yuan, Junying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030951/ https://www.ncbi.nlm.nih.gov/pubmed/36969188 http://dx.doi.org/10.3389/fimmu.2023.1159743 |
Ejemplares similares
-
Targeting RIPK1 for the treatment of human diseases
por: Degterev, Alexei, et al.
Publicado: (2019) -
RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
por: Ke, Dan, et al.
Publicado: (2023) -
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
por: Mifflin, Lauren, et al.
Publicado: (2020) -
Comprehensive Evolutionary Analysis of Lamprey TNFR-Associated Factors (TRAFs) and Receptor-Interacting Protein Kinase (RIPKs) and Insights Into the Functional Characterization of TRAF3/6 and RIPK1
por: Hou, Jianqiang, et al.
Publicado: (2020) -
RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
por: Barbosa, Laiana A., et al.
Publicado: (2018)